Allostery Investments LP
Allostery Investments LP is a hedge fund manager and registered investment adviser headquartered in Stamford, Connecticut. It is incorporated as a Delaware limited partnership. The firm's most recent SEC filings date from 2025. Principals include Christopher Staral. Allostery Investments manages assets predominantly through private investment funds, such as Allostery Master Fund LP (Cayman) and Allostery Fund LP (US).
Investment Strategy
Allostery Investments LP operates as a hedge fund manager, managing portfolios with exposure to a range of public equity and ETF instruments. The firm's recent holdings span biotechnology, healthcare, and technology sectors, using various strategies including long/short equity and derivatives such as calls and puts on indexes and sector-focused ETFs. The firm’s approach is driven by sector and security selection, with a focus on actively trading both US and international equities and employing tactical allocations in growth-oriented sectors such as biotech.
Top Holdings
Equity Positions (19)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ABVX | ABIVAX SA | 16.31% | $1.3M | 167,350 | $6.83 | $7.65 | -$5.6M |
A AKRO | AKERO THERAPEUTICS INC | 15.29% | $1.2M | 22,500 | $43.06 | $53.36 | +$472.0K |
A AMLX | AMYLYX PHARMACEUTICALS INC | 9.81% | $770.0K | 120,119 | $3.54 | $6.41 | -$172.0K |
C CNTA | CENTESSA PHARMACEUTICALS PLC | 8.79% | $689.9K | 52,500 | $16.14 | $13.14 | -$4.8M |
E EOLS | EVOLUS INC | 7.04% | $552.6K | 60,000 | $11.04 | $9.21 | -$4.4M |